MedPath

Effect of supplementation in treatment of women with gestational diabetes

Phase 3
Conditions
Gestational diabetes.
Diabetes mellitus in pregnancy, unspecified
O24.9
Registration Number
IRCT201706075623N119
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
90
Inclusion Criteria

Patients with gestational diabetes
Aged 18 to 40 years

Exclusion Criteria

Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Smokers
Taking vitamin D, probiotic and/or symbiotic supplements during the last 3 months prior to the intervention
Insulin therapy during the intervention

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Using HOMA formula.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath